HAVCR2 and acute myeloid leukemia: In summary, our study elucidates the link between oncogenic mutations in AML and TIM-3 ligand expression and identifies anti–TIM-3 treatment as a strategy for enhancing the GVL effect through metabolic and transcriptional reprogramming of Tc after allo-HCT.